|
Mean age at first sample (SD)(*)
|
37.7 (13.1)
|
34.9 (12.8)
|
0.47
|
|
% Female (n)(*)
|
77.8 (14)
|
83.9 (26)
|
0.71
|
|
Ethnicity(*)
| | |
0.41
|
|
% AC (n)
|
27.8 (5)
|
41.9 (13)
| |
|
% C (n)
|
61.1 (11)
|
38.7 (12)
|
|
% Other (n)
|
11.1 (2)
|
19.3 (6)
|
|
Median anti-dsDNA IU/ml (IQR)(**) (†)
|
29 (13, 97)
|
82 (17, 171)
|
0.18
|
|
Mean C3 g/l (SD)(**)
|
1.0 (0.2)
|
0.9 (0.3)
|
0.10
|
|
Median Global BILAG score (IQR)(**) (†)
|
5 (2, 8)
|
5 (3, 10)
|
0.22
|
|
% anti-Sm positive (n)(*)
|
0.0 (0)
|
35.5 (11)
|
0.004
|
|
% anti-RNP positive (n)(*)
|
27.8 (5)
|
32.3 (10)
|
1.00
|
|
% anti-Ro-positive (n)(*)
|
38.9 (7)
|
45.2 (14)
|
0.77
|
|
% anti-La positive (n)(*)
|
16.7 (3)
|
9.7 (3)
|
0.66
|
|
% on hydroxychloroquine (n)(**)
|
42.1 (61)
|
44.7 (113)
|
0.66
|
|
% on immunosuppressants (n)(**)
|
25.7 (37)
|
63.2 (160)
|
0.001
|
|
% on ≥5 mg/day corticosteroids (n)(**)
|
68.1 (98)
|
78.3 (198)
|
0.31
|
